Abstract
Progressive pseudorheumatoid dysplasia (PPRD) is a genetic bone disorder characterised by the progressive degeneration of articular cartilage that leads to pain, stiffness and joint enlargement. As PPRD is a rare disease, available literature is mainly represented by single case reports and only a few larger case series. Our aim is to review the literature concerning clinical, laboratory and radiological features of PPRD. PPRD is due to a mutation in Wnt1-inducible signalling protein 3 (WISP3) gene, which encodes a signalling factor involved in cartilage homeostasis. The disease onset in childhood and skeletal changes progresses over time leading to significant disability. PPRD is a rare condition that should be suspected if a child develops symmetrical polyarticular involvement without systemic inflammation, knobbly interphalangeal joints of the hands, and gait abnormalities. A full skeletal survey, or at least a lateral radiograph of the spine, can direct towards a correct diagnosis that can be confirmed molecularly. More than 70 WISP3 mutations have so far been reported. Genetic testing should start with the study of genomic DNA extracted from blood leucocytes, but intronic mutations in WISP3 causing splicing aberrations can only be detected by analysing WISP3 mRNA, which can be extracted from cultured skin fibroblasts. A skin biopsy is, therefore, indicated in patients with typical PPRD findings and negative mutation screening of genomic DNA.
Similar content being viewed by others
References
Wynne-Davies R, Hall C, Ansell BM (1982) Spondyloepiphyseal dysplasia tarda with progressive arthropathy. A new disorder of autosomal recessive inheritance. J Bone Jt Surg Br 64:442–445
Warman ML, Cormier-Daire V, Hall C et al (2011) Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet Part A 155:943–968. https://doi.org/10.1002/ajmg.a.33909
Teebi AS, Al Awadi SA (1986) Spondyloepiphyseal dysplasia tarda with progressive arthropathy: a rare disorder frequently diagnosed among Arabs. J Med Genet 23:189–191
Delague V, Chouery E, Corbani S et al (2005) Molecular study of WISP3 in nine families originating from the Middle-East and presenting with progressive pseudorheumatoid dysplasia: Identification of two novel mutations, and description of a founder effect. Am J Med Genet 138 A:118–126. https://doi.org/10.1002/ajmg.a.30906
Dalal A, Bhavani SL, Togarrati PP et al (2012) Analysis of the WISP3 gene in Indian families with progressive pseudorheumatoid dysplasia. Am J Med Genet Part A 158 A:2820–2828. https://doi.org/10.1002/ajmg.a.35620
Bhavani GS, Shah H, Dalal AB et al (2015) Novel and recurrent mutations in WISP3 and an atypical phenotype. Am J Med Genet Part A 167:2481–2484. https://doi.org/10.1002/ajmg.a.37164
Rai E, Mahajan A, Kumar P et al (2016) Whole Exome screening identifies novel and recurrent wisp3 mutations causing progressive pseudorheumatoid dysplasia in Jammu and Kashmir-India. Sci Rep 6:7–11. https://doi.org/10.1038/srep27684
Montané LS, Marín OR, Rivera-Pedroza CI et al (2016) Early severe scoliosis in a patient with atypical progressive pseudorheumatoid dysplasia (PPD): identification of two WISP3 mutations, one previously unreported. Am J Med Genet Part A 170:1595–1599. https://doi.org/10.1002/ajmg.a.37619
Duarte-Salazar C, Santillán-Chapa CG, Martínez-Coria E et al (2013) Displasia progresiva seudorreumatoide. Desorden genético raro que simula artritis idiopática juvenil. Reumatol Clin 9:316–318. https://doi.org/10.1016/j.reuma.2012.08.001
Hurvitz JR, Suwairi WM, Van Hul W et al (1999) Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 23:94–98. https://doi.org/10.1038/12699
Garcia Segarra N, Mittaz L, Campos-Xavier AB et al (2012) The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): a review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals. Am J Med Genet Part C Semin Med Genet 160 C:217–229. https://doi.org/10.1002/ajmg.c.31333
Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417. https://doi.org/10.1007/s00296-011-1999-3
Yang GP, Lau LF (1991) Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Diff 2:351–357
Kireeva ML, Latinkić BV, Kolesnikova TV et al (1997) Cyr61 and Fisp12 Are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res 233:63–77. https://doi.org/10.1006/excr.1997.3548
Lau LF, Lam SC-T (1999) The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248:44–57. https://doi.org/10.1006/excr.1999.4456
Katsube K, Sakamoto K, Tamamura Y, Yamaguchi A (2010) Role of CCN, a vertebrate specific gene family, in development. Dev Growth Diff 51:55–67. https://doi.org/10.1111/j.1440-169X.2009.01077.x
Zuo GW, Kohls CD, He BC et al (2010) The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol 25:795–806. https://doi.org/10.1111/j.1365-2958.2010.07165.x.Characterization
Sen M, Cheng YH, Goldring MB et al (2004) WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes. Arthritis Rheum 50:488–497. https://doi.org/10.1002/art.20005
Nakamura Y, Weidinger G, Liang JO et al (2007) The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling. J Clin Invest 117:3075–3086. https://doi.org/10.1172/JCI32001
Yang Y, Liao E (2007) Mutant WISP3 triggers the phenotype shift of articular chondrocytes by promoting sensitivity to IGF-1 hypothesis of spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA). Med Hypotheses 68:1406–1410. https://doi.org/10.1016/j.mehy.2006.06.046
Cui R-R, Huang J, Yi L et al (2007) WISP3 suppresses insulin-like growth factor signaling in human chondrocytes. Mol Cell Endocrinol 279:1–8. https://doi.org/10.1016/J.MCE.2007.08.007
Repudi SR, Patra M, Sen M (2013) WISP3-IGF1 interaction regulates chondrocyte hypertrophy. J Cell Sci 126:1650–1658. https://doi.org/10.1242/jcs.119859
Miller DS, Sen M (2007) Potential role of WISP3 (CCN6) in regulating the accumulation of reactive oxygen species. Biochem Biophys Res Commun 355:156–161. https://doi.org/10.1016/j.bbrc.2007.01.114
Davis L, Chen Y, Sen M (2006) WISP-3 functions as a ligand and promotes superoxide dismutase activity. Biochem Biophys Res Commun 342:259–265. https://doi.org/10.1016/j.bbrc.2006.01.132
Wang M, Man XF, Liu YQ et al (2013) Dysfunction of collagen synthesis and secretion in chondrocytes induced by Wisp3 mutation. Int J Endocrinol. https://doi.org/10.1155/2013/679763
Spranger J, Albert C, Schilling F et al (1983) Progressive pseudorheumatoid arthropathy of childhood (PPAC): a hereditary disorder simulating juvenile rheumatoid arthritis. Am J Med Genet 14:399–401. https://doi.org/10.1002/ajmg.1320140224
Gao YS, Ding H, Zhang CQ (2013) Total hip arthroplasty in a 17-year-old girl with progressive pseudorheumatoid dysplasia. J Clin Rheumatol 19:138–141. https://doi.org/10.1097/RHU.0b013e318289bf35
Zhou H, De Bu YH, Peng YQ et al (2007) Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation. J Mol Med 85:985–996. https://doi.org/10.1007/s00109-007-0193-2
Bhavani GS, Shah H, Shukla A et al (1993) Progressive pseudorheumatoid dysplasia. University of Washington, Seattle
Neerinckx B, Thues C, Wouters C et al (2015) A homozygous deletion of exon 1 in WISP3 causes progressive pseudorheumatoid dysplasia in two siblings. Hum Genome Var 2:15049. https://doi.org/10.1038/hgv.2015.49
Temiz F, Ozbek MN, Kotan D et al (2011) A homozygous recurring mutation in WISP3 causing progressive pseudorheumatoid arthropathy. J Pediatr Endocrinol Metab 24:105–108. https://doi.org/10.1515/JPEM.2011.117
Madhuri V, Santhanam M, Rajagopal K et al (2016) WISP3 mutational analysis in Indian patients diagnosed with progressive pseudorheumatoid dysplasia and report of a novel mutation at p.Y198. Bone Jt Res 5:301–306. https://doi.org/10.1302/2046-3758.57.2000520
Rasore-Quartino A, Camera A, Camera G (1993) Spondylo-epiphyseal dysplasia tarda with progressive arthropathy: description of a patient whose mother showed minimal features of the disease. Pathologica 85:225–231
Ekbote AV, Danda D, Kumar S et al (2013) A descriptive analysis of 14 cases of progressive-psuedorheumatoid-arthropathy of childhood from south India: review of literature in comparison with Juvenile Idiopathic Arthritis. Semin Arthritis Rheum 42:582–589. https://doi.org/10.1016/j.semarthrit.2012.09.001
Sun J, Xia W, He S et al (2012) Novel and recurrent mutations of WISP3 in two Chinese families with progressive pseudorheumatoid dysplasia. PLoS One. https://doi.org/10.1371/journal.pone.0038643
Archik SG, Kamat RD (1990) Progressive pseudorheumatoid chondrodysplasia simulating juvenile rheumatoid arthritis. Indian J Pediatr 57:785–788
el-Shanti HE, Omari HZ, Qubain HI (1997) Progressive pseudorheumatoid dysplasia: report of a family and review. J Med Genet 34:559–563. https://doi.org/10.1136/jmg.34.7.559
Cogulu O, Ozkinay F, Ozkinay C et al (1999) Progressive pseudorheumatoid arthropathy of childhood. Indian J Pediatr 66(3):455–460
Mampaey S, Vanhoenacker F, Boven K et al (2000) Progressive pseudorheumatoid dysplasia. Eur Radiol 10:1832–1835. https://doi.org/10.1007/s003300000518
Balci S, Aypar E, Kasapçopur Ö et al (2001) An eleven-year-old female Turkish patient with progressive pseudorheumatoid dysplasia mimicking juvenile idiopathic arthritis [3]. Clin Exp Rheumatol 19:759
Kaya A, Ozgocmen S, Kiris A, Ciftci I (2005) Clinical and radiological diagnosis of progressive pseudorheumatoid dysplasia in two sisters with severe polyarthropathy. Clin Rheumatol 24:560–564. https://doi.org/10.1007/s10067-005-1086-9
Bennani L, Amine B, Ichchou L et al (2007) Progressive pseudorheumatoid dysplasia: three cases in one family. Jt Bone Spine 74:393–395. https://doi.org/10.1016/j.jbspin.2006.11.014
Shivanand G, Jain V, Lal H (2007) Progressive pseudorheumatoid chondrodysplasia of childhood. Singap Med J 48:151–153
Al Kaissi A, Chehida F, Ben, Ghachem M, Ben et al (2007) Ischiopubic and odontoid synchondrosis in a boy with progressive pseudorheumatoid chondrodysplasia. Pediatr Rheumatol 5:1–6. https://doi.org/10.1186/1546-0096-5-19
Al Kaissi A, Grill F, Jcpsp (2010) Clinicoradiographic presentation of a girl with progressive pseudorheumatoid arthropathy.[Erratum appears in J Coll Physicians Surg Pak. 2010 Apr;20(4):292]. J Coll Phys Surg Pak 20:140–141
Ye J, Zhang HW, Qiu WJ et al (2012) Patients with progressive pseudorheumatoid dysplasia: from clinical diagnosis to molecular studies. Mol Med Rep 5:190–195. https://doi.org/10.3892/mmr.2011.619
Yang X, Song Y, Kong Q (2013) Diagnosis and surgical treatment of progressive pseudorheumatoid dysplasia in an adult with severe spinal disorders and polyarthropathy. Jt Bone Spine 80:650–652. https://doi.org/10.1016/j.jbspin.2013.03.006
Mandal SK, Ghosh S, Mondal SS, Chatterjee S (2014) Spondyloepiphyseal dysplasia tarda with progressive arthropathy associated with subcapsular cataract. BMJ Case Rep 2013–2015. https://doi.org/10.1136/bcr-2013-202938
Cassa CA, Smith SE, Docken W et al (2016) An argument for early genomic sequencing in atypical cases: a WISP3 variant leads to diagnosis of progressive pseudorheumatoid arthropathy of childhood. Rheumatol (United Kingdom) 55:586–589. https://doi.org/10.1093/rheumatology/kev367
Luo H, Shi C, Mao C et al (2015) A novel compound WISP3 mutation in a Chinese family with progressive pseudorheumatoid dysplasia. Gene 564:35–38. https://doi.org/10.1016/j.gene.2015.03.029
Yu Y, Hu M, Xing X et al (2015) Identification of a mutation in the WISP3 gene in three unrelated families with progressive pseudorheumatoid dysplasia. Mol Med Rep 12:419–425. https://doi.org/10.3892/mmr.2015.3430
Al Kaissi A, Ryabykh S, Ochirova P et al (2017) Muscle Weakness. J Investig Med High Impact Case Rep 5:232470961668958. https://doi.org/10.1177/2324709616689583
Sailani MR, Chappell J, Jingga I et al (2018) WISP3 mutation associated with pseudorheumatoid dysplasia. Mol Case Stud 4:a001990. https://doi.org/10.1101/mcs.a001990
Kaibara N, Takagishi K, Katsuki I et al (1983) Spondyloepiphyseal dysplasia tarda with progressive arthropathy. Skelet Radiol 10:13–16. https://doi.org/10.1007/BF00355384
Kocyigit H, Arkun R, Ozkinay F et al (2000) Spondyloepiphyseal dysplasia tarda with progressive arthropathy. Clin Rheumatol 19:238–241
Arslanoğlu S, Murat H, Ferah G (2000) Spondyloepiphyseal dysplasia tarda with progressive arthropathy: An important form of osteodysplasia in the differential diagnosis of juvenile rheumatoid arthritis. BMC Med Genet 18:561–563
Bal S, Kocyigit H, Turan Y et al (2009) Spondyloepiphyseal dysplasia tarda: four cases from two families. Rheumtol Int 29:699–702. https://doi.org/10.1007/s00296-008-0746-x
Cefle A, Cefle K, Tunaci M et al (2006) A case of progressive pseudorheumatoid arthropathy of ‘childhood’ with the diagnosis delayed to the fifth decade. Int J Clin Pract 60:1306–1309. https://doi.org/10.1111/j.1742-1241.2005.00662.x
Tuǧ E, Şenocak E (2008) Spondyloepiphyseal dysplasia tarda with progressive arthropathy with delayed diagnosis. Turk J Med Sci 38:83–89
Hu Q, Liu J, Wang Y et al (2017) Delayed-onset of progressive pseudorheumatoid dysplasia in a Chinese adult with a novel compound WISP3 mutation: a case report. BMC Med Genet 18:1–5 https://doi.org/10.1186/s12881-017-0507-3
Taşpinar Ö, Keleşoʇlu FM, Bakan S et al (2013) Progressive pseudorheumatoid dysplasia misdiagnosed as seronegative juvenile idiopathic arthritis. Turkiye Fiz Tip ve Rehabil Derg 59:458. https://doi.org/10.4274/tftr.24.59.1
Hartmann M, Merker J, Haefner R et al (2016) Biomechanics of walking in adolescents with progressive pseudorheumatoid arthropathy of childhood leads to physical activity recommendations as therapeutic focus. Clin Biomech 31:93–99. https://doi.org/10.1016/j.clinbiomech.2015.09.015
Kiliç G, Kiliç E, Akgül Ö et al (2016) An unusual coexistence of progressive pseudorheumatoid dysplasia and relapsing polychondritis. Arch Rheumatol 31:290–294. https://doi.org/10.5606/ArchRheumatol.2016.5994
Yan W, Dai J, Xu Z et al (2016) Novel WISP3 mutations causing progressive pseudorheumatoid dysplasia in two Chinese families. Hum Genome Var 3:16041. https://doi.org/10.1038/hgv.2016.41
Bradley JD (1987) Pseudoseptic pseudogout in progressive pseudorheumatoid arthritis of childhood. Ann Rheum Dis 46:709–712. https://doi.org/10.1136/ard.46.9.709
Yue H, Zhang ZL, He JW (2009) Identification of novel mutations in WISP3 gene in two unrelated Chinese families with progressive pseudorheumatoid dysplasia. Bone 44:547–554. https://doi.org/10.1016/j.bone.2008.11.005
Ehl S, Uhl M, Berner R et al (2004) Clinical, radiographic, and genetic diagnosis of progressive pseudorheumatoid dysplasia in a patient with severe polyarthropathy. Rheumatol Int 24:53–56. https://doi.org/10.1007/s00296-003-0341-0
Yildizgoren MT, Sahin A, Osmanoglu K, Turhanoglu AD (2015) Progressive pseudorheumatoid dysplasia with delayed diagnosis. JCR J Clin Rheumatol 21:329. https://doi.org/10.1097/RHU.0000000000000282
Rezai-Delui H, Mamoori G, Sadri-Mahvelati E, Noori NM (1994) Progressive pseudorheumatoid chondrodysplasia: a report of nine cases in three families. Skelet Radiol 23:411–419
Kozlowski K, Kennedy J, Lewis IC (1986) Radiographic features of progressive pseudorheumatoid arthritis. Australas Radiol 30:244–250
Wickrematilake G (2017) Progressive pseudorheumatoid dysplasia or JIA? Case Rep Rheumatol 2017:1609247. https://doi.org/10.1155/2017/1609247
Chakraborty PP, Biswas SN, Patra S, Santra G (2016) Progressive pseudorheumatoid dysplasia: a close mimicker of juvenile idiopathic arthritis. BMJ Case Rep 2016:1–2. https://doi.org/10.1136/bcr-2016-214849
Legius E, Mulier M, van Damme B, Fryns JP (1993) Progressive pseudorheumatoid arthritis of childhood (PPAC) and normal adult height. Clin Genet 44:152–155. https://doi.org/10.1111/j.1399-0004.1993.tb03868.x
Liu L, Li N, Zhao Z et al (2015) Novel WISP3 mutations causing spondyloepiphyseal dysplasia tarda with progressive arthropathy in two unrelated Chinese families. Jt Bone Spine 82:125–128. https://doi.org/10.1016/j.jbspin.2014.10.005
Nassar K, Rachidi W, Janani S, Mkinsi O (2015) Dysplasie polyépiphysaire pseudorhumatoïde, destructrice. Press Medicale 44:961–964. https://doi.org/10.1016/j.lpm.2015.03.017
Oestreich AE (2002) Mega os trigonum in progressive pseudorheumatoid dysplasia. Pediatr Radiol 32:46–48. https://doi.org/10.1007/s00247-001-0576-4
Urtizberea JA, Thambyayah M, Nishino I, Megarbane A (2005) Non-collagenic etiologies of muscle weakness with joint deformities: about two paradigmatic case reports. Acta Myol 24:78–79
Chouery E, Corbani S, Dahmen J et al (2017) Progressive pseudorheumatoid dysplasia in North and West Africa: clinical description in ten patients with mutations of WISP3. Egypt J Med Hum Genet 18:299–303. https://doi.org/10.1016/j.ejmhg.2016.11.004
Winchester P, Grossman H, Lim WN, Danes BS (1969) A new acid mucopolysaccharidosis with skeletal deformities simulating rheumatoid arthritis. Am J Roentgenol Radium Ther Nucl Med 106:121–128
Kozlowski K, Marik I, Marikova O et al (2004) Czech dysplasia metatarsal type. Am J Med Genet 129 A:87–91. https://doi.org/10.1002/ajmg.a.30132
Tzschach A, Tinschert S, Kaminsky E et al (2008) Czech dysplasia: report of a large family and further delineation of the phenotype. Am J Med Genet Part A 146:1859–1864. https://doi.org/10.1002/ajmg.a.32389
Tiller GE, Polumbo PA, Weis MA et al (1995) Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type. Nat Genet 11:87–89. https://doi.org/10.1038/ng0995-87
Marik I, Marikova O, Zemkova D et al (2004) Dominantly inherited progressive pseudorheumatoid dysplasia with hypoplastic toes. Skelet Radiol 33:157–164. https://doi.org/10.1007/s00256-003-0708-z
Walter K, Tansek M, Tobias ES et al (2007) COL2A1-related skeletal dysplasias with predominant metaphyseal involvement. Am J Med Genet Part A 143A:161–167. https://doi.org/10.1002/ajmg.a.31516
Robin NH, Moran RT, Ala-Kokko L (2000) Stickler syndrome. In: Adam MP, Ardinger HH, Pagon RA et al (eds) GeneReviews®. University of Washington, Seattle, WA, pp 1993–2018
Jurgens J, Sobreira N, Modaff P, et al (2015) Novel COL2A1 Variant (c.619G>A, p.Gly207Arg) manifesting as a phenotype similar to progressive pseudorheumatoid dysplasia and spondyloepiphyseal dysplasia, stanescu type. Hum Mutat 36:1004–1008. https://doi.org/10.1002/humu.22839
Isidor B, Poignant S, Picherot G et al (2012) Progressive polyepiphyseal dysplasia with arthropathy: a distinct disorder from idiopathic juvenile arthritis and pseudorheumatoid dysplasia? Am J Med Genet Part A 158 A:1754–1758. https://doi.org/10.1002/ajmg.a.35424
Pedini N, Putz P (2010) Progressive pseudorheumatoid chondrodysplasia. Case report. Rev Med Brux 31:533–537
Funding
The authors received no specific funding for this work.
Author information
Authors and Affiliations
Contributions
ST and GF were involved in the conceptualization, planning and execution of this review. All authors contributed to data synthesis and interpretation, simultaneous draft review and the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from the patient whose photograph and radiological image are displayed in the present article.
Additional information
No part of the article, including text, graphics, and ideas, has been copied from elsewhere.
Rights and permissions
About this article
Cite this article
Torreggiani, S., Torcoletti, M., Campos-Xavier, B. et al. Progressive pseudorheumatoid dysplasia: a rare childhood disease. Rheumatol Int 39, 441–452 (2019). https://doi.org/10.1007/s00296-018-4170-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-018-4170-6